SIREN : 508386604
DUFRANOL is a French company founded 17 years ago, specialized in the sector Activités des sociétés holding. Based in BUC (78530), this company of category PME shows in 2022 a revenue of 1.2 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|
| Revenue | 1 197 830 € | 1 064 060 € | 848 350 € | 1 016 989 € | 1 027 543 € | 918 283 € | 900 055 € |
| Net income | 621 730 € | 12 683 € | 57 901 € | 30 770 € | 82 240 € | 251 372 € | 196 385 € |
| EBITDA | 21 667 € | 42 580 € | 36 662 € | 8 249 € | 63 670 € | 18 076 € | -3 930 € |
| Net margin | 51.9% | 1.2% | 6.8% | 3.0% | 8.0% | 27.4% | 21.8% |
In 2022, DUFRANOL achieves revenue of 1.2 M€. Revenue is growing positively over 7 years (CAGR: +4.9%). Vs 2021, growth of +13% (1.1 M€ -> 1.2 M€). After deducting consumption (0 €), gross margin stands at 1.2 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 22 k€, representing 1.8% of revenue. Warning negative scissor effect: despite revenue change (+13%), EBITDA varies by -49%, reducing margin by 2.2 pts. This reflects costs rising faster than revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 622 k€, i.e. 51.9% of revenue. This profit can be retained or distributed to shareholders.
1 197 830 €
1 197 830 €
21 667 €
8 387 €
621 730 €
1.8%
The debt ratio (= Financial debt / Equity x 100) stands at 32%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 72%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 1.2 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 50.6% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
32.006%
71.91%
50.609%
1.191
68.1%
In 2022, the debt ratio of DUFRANOL (32.01) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2022, the financial autonomy of DUFRANOL (71.9%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2022, the repayment capacity of DUFRANOL (1.19) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 1119.91. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
1119.912
0.0
In 2022, the liquidity ratio of DUFRANOL (1119.91) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2022, the interest coverage of DUFRANOL (0.0x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 136 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 50 days. The gap of 86 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Overall, WCR represents 466 days of revenue, i.e. 1.6 M€ to permanently finance. Over 2016-2022, WCR increased by +233%, requiring additional financing.
1 551 370 €
136 j
50 j
0 j
466 j
Based on 70 transactions of similar company sales
in 2022,
the value of DUFRANOL is estimated at
727 513 €
(range 261 256€ - 1 415 005€).
With an EBITDA of 21 667€, the sector multiple of 2.4x is applied.
The price/revenue ratio is 0.67x
(in line with sector norms).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 70 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare DUFRANOL with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sociétés holding
The revenue of DUFRANOL in 2022 is 1.2 M€.
Yes, DUFRANOL generated a net profit of 622 k€ in 2022.
The headquarters of DUFRANOL is located in BUC (78530), in the department Yvelines.
The tax return of DUFRANOL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
DUFRANOL operates in the sector Activités des sociétés holding (NAF code 64.20Z). See the 'Sector positioning' section above to compare the company with its competitors.